Design Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Design Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2021 to Q3 2024.
  • Design Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.4M, a 22.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.4M -$710K -22.8% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $2.58M -$697K -21.3% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $2.76M -$685K -19.9% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $2.94M -$674K -18.7% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $3.11M -$662K -17.5% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $3.28M -$652K -16.6% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $3.45M -$35K -1.01% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $3.61M -$2K -0.06% Dec 31, 2022 10-K 2024-03-19
Q3 2022 $3.77M +$30K +0.8% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $3.93M Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $3.48M Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $3.61M Dec 31, 2021 10-K 2023-03-14
Q3 2021 $3.74M Sep 30, 2021 10-Q 2021-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.